Abstract:BACKGROUND & AIMS: Alterations in the intestinal microbiota affect development of colorectal cancer and drug metabolism. We studied whether the intestinal microbiota affect the ability of aspirin to reduce colon tumor development in mice. METHODS: We performed studies with APCmin/ thorn mice and mice given azoxymethane and dextran sulfate sodium to induce colorectal carcinogenesis. Some mice were given antibiotics to deplete intestinal microbes, with or without aspirin, throughout the entire experiment. Germ-free mice were studied in validation experiments. Colon tissues were collected and analyzed by histopathology, quantitative reverse-transcription polymerase chain reaction, and immunoblots. Blood samples and gut luminal contents were analyzed by liquid chromatography/ mass spectrometry and an arylesterase activity assay. Fecal samples were analyzed by 16S ribosomal RNA gene and shotgun metagenome sequencing. RESULTS: Administration of aspirin to mice reduced colorectal tumor number and load in APCmin/ thorn mice and mice given azoxymethane and dextran sulfate sodium that had been given antibiotics (depleted gut microbiota), but not in mice with intact microbiota. Germfree mice given aspirin developed fewer colorectal tumors than conventionalized germ-free mice given aspirin. Plasma levels of aspirin were higher in mice given antibiotics than in mice with intact gut microbiota. Analyses of luminal contents revealed that aerobic gut microbes, including Lysinibacillus sphaericus, degrade aspirin. Germ-free mice fed L sphaericus had lower plasma levels of aspirin than germ-free mice that were not fed this bacterium. There was an inverse correlation between aspirin dose and colorectal tumor development in conventional mice, but this correlation was lost with increased abundance of L sphaericus. Fecal samples from mice fed aspirin were enriched in Bifidobacterium and Lactobacillus genera, which are considered beneficial, and had reductions in Alistipes finegoldii and Bacteroides fragili, which are considered pathogenic. CONCLUSIONS: Aspirin reduces development of colorectal tumors in APCmin/ thorn mice and mice given azoxymethane and dextran sulfate sodium, depending on the presence of intestinal microbes. L sphaericus in the gut degrades aspirin and reduced its chemopreventive effects in mice. Fecal samples from mice fed aspirin were enriched in beneficial bacteria, with reductions in pathogenic bacteria.

Modulation of Aspirin on Gene Expression and Release of MMP-2/9 and TIMP-1 in Macrophages of Mice

Regulation on RhoA in Vascular Smooth Muscle Cells under Inflammatory Stimulation Proposes a Novel Mechanism Mediating the Multiple-Beneficial Action of Acetylsalicylic Acid

Cyclooxygenase-Independent Effects of Aspirin on Ht-29 Human Colon Cancer Cells, Revealed by Oligonucleotide Microarrays

Effect of Atorvastatin on MMP-9 and Tissue Factor Induced by Oxldl in Human Monocytes-Derived Macrophages

Acetylsalicylic Acid Regulates Overexpressed Small GTPase RhoA in Vascular Smooth Muscle Cells Through Prevention of New Synthesis and Enhancement of Protein Degradation.

Mir-34B-3p May Promote Antiplatelet Efficiency of Aspirin by Inhibiting Thromboxane Synthase Expression

Effect of S-aspirin, a Novel Hydrogen-Sulfide-releasing Aspirin (ACS14), on Atherosclerosis in Apoe-Deficient Mice

Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE-/- mice

Validation of Aspirin Response-Related Transcripts in Patients with Coronary Artery Disease and Preliminary Investigation on CMTM5 Function.

Effects of aspirin and tumor necrosis factor-α on the gene expression of adipocytokines in adipocytes

Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages

Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-Κda Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages

Aspirin Inhibits the Proliferation of Synovium-Derived Mesenchymal Stem Cells by Arresting the Cell Cycle in the G0/G1 Phase

Identification of TMEM208 and PQLC2 As Reference Genes for Normalizing Mrna Expression in Colorectal Cancer Treated with Aspirin

Aspirin increases apolipoprotein-A-I-mediated cholesterol efflux via enhancing expression of ATP-binding cassette transporter A1.

IDENTIFICATION OF ASPIRIN RESPONSE RELATED GENE PROFILES IN THE ELDERLY POPULATION WITH CORONARY ARTERY DISEASE

Inhibitory Effect of Apolipoprotein A-I on Matrix Metalloproteinase-2 Expression in Vivo and in Vitro.

Inhibition of Emmprin and Mmp-9 Expression by Epigallocatechin-3-Gallate Through 67-Kda Laminin Receptor in Pma-Induced Macrophages

Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce Its Bioavailability and Chemopreventive Effects.

The Effect of Guanxinshutong Capsule on the Expression of Matrix Metalloproteinases-9 and Tissue Matrix Metalloproteinase Inhibitor-1 of Atherosclerotic Plaque in ApoE-/-Mice

Aspirin eugenol ester ameliorates LPS-induced inflammatory responses in RAW264.7 cells and mice